The immune-monitoring role of Fractalkine, Mig, Ip-10, C4d, BCA-1, VEGF, NGAL, sTim-3, Granzyme B, IL-17 in Kidney transplant patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-DDT-10002069

Enrollment

Unknown

Registered

2010-11-28

Start date

2010-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney transplant patients

Interventions

Gold Standard:

Index test:

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Kidney transplant patients between 2001.1 and 2010.1; 2. all the patients with complete blood and urine sample.

Exclusion criteria

Exclusion criteria: 1. infection within 1 month after kidney transplantation; 2. maligant tumour after kidney transplantation

Design outcomes

Primary

Measure	Time frame
Fractalkine;Mig;Ip-10;C4d;BCA-1;VEGF;NGAL;sTim-3;Granzyme B;IL-1;	—

Countries

China

Contacts

Public ContactChen jianghua Pengwenhan

zju2001@zju.edu.cn+86 13858099862

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026